Author | Sibylle Loib, MD

Articles

What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?

January 16, 2012

This article provides a comprehensive summary of the knowledge gained from recent neoadjuvant trials conducted with agents targeting HER2, and will put them into perspective with current treatment recommendations from American and European guidelines.